The Delta Variant and Low Vaccine Rates Could Spell Trouble

Vaccines are effective against the variant, but experts worry about states where fewer people are inoculated.

By many metrics, the US is doing relatively well against the pandemic coronavirus. National tallies of cases, hospitalizations, and deaths are all at lows not seen since early last year. Several states have hit the goal of having 70 percent of adults vaccinated with at least one dose, and many areas are easing or lifting health restrictions in response to suppressed transmission levels.

Ars Technica

This story originally appeared on Ars Technica, a trusted source for technology news, tech policy analysis, reviews, and more. Ars is owned by WIRED’s parent company, Condé Nast.

But those hard-fought gains

→ Continue reading at Wired - Science

More from author

Related posts

Advertisment

Latest posts

Deliveroo could leave Spanish market ahead of on-demand labor reclassification

Deliveroo announced today that it is considering leaving the Spanish market, citing limited market share and a long road of investment with “highly uncertain...

For tech firms, the risk of not preparing for leadership changes is huge

Jason Dressel Contributor Jason Dressel is president of History Factory, which helps companies use their history and...

5 Reasons Why Employees Prefer Self-Employment, and Why You Should Use This to Your Advantage

Find employees that care about your business as if it was their own. Free Book Preview: Unstoppable Get a glimpse...